EU health ministers split over a proposal to give certain innovative medicines an extra year of market protection, with EU Health Commissioner arguing the incentive is needed to keep biotech investment in Europe. Incoming Irish presidency, in the meantime, says it will work as quickly as possible.

Amid Europe’s push to catch up in the biotechnology field, the EU health ministers agreed how to tweak rules on modified micro-organisms (GMMs) and the processing of organs.

EU health ministers split over a proposal to give certain innovative medicines an extra year of market protection, with EU Health Commissioner arguing the incentive is needed to…